This year’s technology transfer award from Braunschweig’s Chamber of Industry and Commerce goes to scientists at the Helmholtz Centre for Infection Research (HZI) and its spin-off company InSCREENeX. Together, they have developed technologies for the rapid and cost-efficient production of cell lines with tissue-like characteristics that enable mechanistic studies, drug screening, initial ADME/TOX evaluation and tailored drug development. The approach can be applied to any tissue from any donor and requires only a minimal amount of cells for the starting material. For the biopharmaceutical industry, it provides a powerful tool to speed-up the time- and cost-intensive process of drug discovery, as well as a new and efficient route to research, develop and evaluate personalized medicines.
Ascenion, the HZI’s technology transfer partner, worked closely with the scientists for more than a decade and was instrumental in getting the new company off the ground.
For further information:
See HZI’s press release (available in German language only)
See InSCREENeX’ website